anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Traction

Slide type collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 10,471
Current window 6,571-6,600
Pages 350
Rows per page 30
Slide type: Tractionclear collectionreset all
18 30 60

Slide type

6,571-6,600 of 10,471

filter-aware
08
The slide highlights a conservative growth trend and a high concentration of real estate-secured assets.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
10
The slide uses a two-column layout to contrast external validation (SBA award) with internal program success (niche markets and product offerings).Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
11
Slide 11 of a pitch deck, showing strong deposit stability and growth metrics.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
14
The slide uses a 2x2 grid layout to present four distinct efficiency initiatives.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
16
The slide highlights specific credit quality indicators for Central Pacific Financial Corp.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
17
Includes regulatory capital ratios and historical dividend growth.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
18
Slide 18 of a pitch deck for Central Pacific Financial Corp.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
21
The slide provides a snapshot of CRE portfolio composition as of December 31, 2023, including geographic and investor-type splits.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations 1 hit
12
The chart uses a stacked bar approach to show total vs new learners, with an overlay arrow indicating growth velocity.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
The slide uses a visual timeline/growth chart format to demonstrate the scaling of industry-partnered certifications.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
The slide uses a grid of university logos to demonstrate the scale and breadth of the degree program offerings.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
The slide uses a split-layout with key metrics on the left and trend charts on the right.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes footnotes regarding definitions and one-time benefits.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The slide highlights revenue performance and student count for the Degrees segment, noting 100% segment margin due to the business model.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
03
The slide uses a grid of metrics to demonstrate market dominance and financial health.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
05
The slide uses a chronological structure to demonstrate operational momentum.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
19
Data cut-off: 8 Aug 2023. Includes detailed breakdown of resistance mutations and prior treatment history.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
20
Clinical trial data (ALKOVE-1) showing efficacy of NVL-655 across different patient cohorts.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
21
The chart is a classic swimmer plot used in oncology clinical trials to visualize time-to-event data.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide presents a clinical trial snapshot including patient eligibility criteria and a breakdown of patient enrollment by dose cohort.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
32
Includes a summary table of best responses and a waterfall plot showing percentage change in target lesions by dose cohort.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
Includes clinical trial data from ARROS-1 Phase 1 study.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
35
The chart shows pharmacokinetic curves for four different dose levels against four target efficacy thresholds.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
09
Includes two line charts showing tumor volume reduction over time and a table showing patient incidence for target indications.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes a patient-derived xenograft (PDX) study methodology diagram and a line chart showing tumor volume over time.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a split-column layout to contrast two phases of a clinical trial.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
Data shows tumor regression in treated groups vs growth in control groups over 27 days.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
22
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Traction1 hit
23
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit